NCT05886335View on ClinicalTrials.gov

Influence of Timing PTCy in AlloSCT

CompletedOBSERVATIONAL
Enrollment

180

Participants

Timeline

Start Date

June 26, 2023

Primary Completion Date

November 30, 2024

Study Completion Date

January 31, 2025

Conditions
Cyclophosphamide ToxicityAllogenic Haematopoetic Transplantation
Interventions
DRUG

Cyclophosphamide

Time of administration

Trial Locations (1)

08025

Hospital de la Santa Creu i Sant Pau, Barcelona

All Listed Sponsors
lead

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

OTHER

NCT05886335 - Influence of Timing PTCy in AlloSCT | Biotech Hunter | Biotech Hunter